Nonetheless, pSS patients treated with HCQ have a significant lower BAFF levels in the serum, and an improvement in saliva production (Mumcu et al, 2013), indicating that this drug might be a promising therapy for pSS as well. Here, TNFSF13B is linked to peeling skin syndrome.